DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Neuronal lipofuscinosis caused by Kufs disease/CLN4 DNAJC5 mutations but not by a CSPα/DNAJC5 deficiency
Kufs disease/CLN4 is an autosomal dominant neurodegenerative disorder caused by unknown mechanisms through Leu115Arg and Leu116Δ mutations in the DNAJC5 gene that encodes the synaptic vesicle co-chaperone cysteine string protein α (CSPα/DNAJC5). To investigate the disease mechanisms in vivo, we generated three independent mouse lines overexpressing different versions of CSPα/DNAJC5 under the neuron-specific Thy1 promoter: wild-type (WT), Leu115Arg, and Leu116Δ. Mice expressing mutant Leu115Arg CSPα/DNAJC5 are viable but develop motor deficits. As described in patients with Kufs disease, we observed the pathological lipofuscinosis and intracellular structures resembling granular osmiophilic deposits (GRODs) in the mutant but not in the WT transgenic lines. Microglia engulf lipofuscin and lipofuscin-containing neurons. Notably, conventional or conditional knockout mice lacking CSPα/DNAJC5 did not exhibit any signs of increased lipofuscinosis or GRODs. Our novel mouse models provide a valuable tool to investigate the molecular mechanisms underlying Kufs disease/CLN4. DNAJC5 mutations cause neuronal lipofuscinosis through a cell-autonomous gain of a pathological function of CSPα/DNAJC5., This work was supported by Spanish Agencia Estatal de Investigación and Ministerio de Ciencia, Innovación y Universidades and European Regional Development Fund (ERDF), (MICIU/AEI/10.13039/501100011033, FEDER, UE): BFU2016-76050-P (R.F.-C.), PID2019-105530GB-I00 (R.F.-C.), PID2022-138957NBI00 (R.F.-C.), PID2021-125875OB-I00 (R.L.), BES-2011-046029 (Á.L.-R.), BES-2017-082324 (C.M.-C.), PRE2020/095166 (C.P.-L.), and FPU18/01700 (F.R.-P.); Andalusian Consejería de Universidad, Investigación e Innovación, CUII, P12-CTS-2232, P18FR-2144, CTS-600 (R.F.-C.); Andalusian Consejería de Salud y Consumo, RH-0064-2021 (N.B.); INVESTIGO Program funded by the European Union through the Recovery, Transformation, and Resilience Plan for Andalusia (M.L.C.-V.); Institute of Health Carlos III (ISCIII) and MICIU: FORTALECE (FORT23/00008) and CIBERNED (R.F.-C.); Junta de Comunidades de Castilla-La Mancha, SBPLY/21/180501/000064 (to R.L.); ZonmMW Memorabel/Alzheimer Nederland, no. 733050101 (W.S.)., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-105530GB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-138957NB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-125875OB-I00
,
MICINN / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 BES-2011-046029
,
AEI BES-2017-082324
DOI: http://hdl.handle.net/10261/400667, https://api.elsevier.com/content/abstract/scopus_id/105005828911
HANDLE: http://hdl.handle.net/10261/400667, https://api.elsevier.com/content/abstract/scopus_id/105005828911